Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2003
02/20/2003US20030036138 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036135 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036134 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036133 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036132 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036131 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036130 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036129 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036128 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036127 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036126 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036125 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036124 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036123 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036122 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036120 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders
02/20/2003US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders
02/20/2003US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036117 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036116 Can be used in combination with other mutagenesis methods
02/20/2003US20030036115 Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM6, expressed highly in the small intestine
02/20/2003US20030036114 Nucleotide sequences coding polyopeptide for use in the diagnosis and treatment of cell proliferative disorders
02/20/2003US20030036111 Transport protein for use in the treatment of mitochondrial, tumor, muscle and viral diseases
02/20/2003US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins
02/20/2003US20030036105 Antigen for use in the diagnosis of nematode infections
02/20/2003US20030036101 Use of neuregulin-beta as an indicator and/or target
02/20/2003US20030036099 Isolation of membrane bound ligand-specific complexes
02/20/2003US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders
02/20/2003US20030036092 Directed evolution of enzymes and antibodies
02/20/2003US20030036091 Crystals and structure of LuxS
02/20/2003US20030036089 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
02/20/2003US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders
02/20/2003US20030036074 Novel nucleic acid sequences encoding human transporters, a human atpase molecule, a human ubiquitin hydrolase-like molecule, a human ubiquitin conjugating enzyme-like molecule, and uses therefor
02/20/2003US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders
02/20/2003US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030035820 Crosslinked keratin; thin film; wound healing agents, tissues, diffusion membranes
02/20/2003US20030035816 Soluble ctla4 mutant molecules and uses thereof
02/20/2003US20030035815 Recombitope peptides
02/20/2003US20030035814 Cloning Dna; prevention reproduction; gene therapy
02/20/2003US20030035811 Method of inactivating microorganisms
02/20/2003US20030035809 Nucleic acids; veterinary medicine
02/20/2003US20030035808 Complexing heat shock proteins; anticancer agents
02/20/2003US20030035805 Polysaccharide-protein complex; passivation vaccine
02/20/2003US20030035794 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
02/20/2003US20030035793 Novel immune response targeting molecules
02/20/2003US20030035792 Recombinant MVA virus, and the use thereof
02/20/2003US20030035791 Modulation of p57kip2 expression and uses thereof in the treatment of diabetes and hyperinsulinism of infancy
02/20/2003US20030035790 Anticancer agents, antinflamamtory agents, infection therapy
02/20/2003US20030035789 Purging lymphocytes
02/20/2003US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003CA2457694A1 Platelet-derived growth factor protection of cardiac myocardium
02/20/2003CA2457448A1 Human smooth muscle myosin heavy chain
02/20/2003CA2457437A1 A novel cancer marker and uses therefor in the diagnosis of cancer
02/20/2003CA2457424A1 Molecular interactions in cells
02/20/2003CA2457400A1 Modulation of leukocyte-endothelial interactions following ischemia
02/20/2003CA2457349A1 Sub-unit vaccine for infectious pancreatic necrosis virus
02/20/2003CA2456979A1 Yield-related polynucleotides and polypeptides in plants
02/20/2003CA2456972A1 Stress-related polynucleotides and polypeptides in plants
02/20/2003CA2456964A1 Melanin-concentrating hormone antagonists
02/20/2003CA2456928A1 Cellular virus receptors and methods of use
02/20/2003CA2456882A1 Modified cyclic nucleotide gated ion channel (cng) comprising methionine or valine substitutions at t537 and uses thereof
02/20/2003CA2456881A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
02/20/2003CA2456857A1 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
02/20/2003CA2456786A1 Genetic products of ashbya gossypii, associated with transmembrane transport
02/20/2003CA2456708A1 Crystal forms and mutants of rank ligand
02/20/2003CA2456607A1 Uses of mammalian cytokine; related reagents
02/20/2003CA2456571A1 Human secreted proteins, their encoding polynucleotides, and uses thereof
02/20/2003CA2456390A1 Fusion proteins for insect control
02/20/2003CA2456369A1 Proteins associated with cell growth, differentiation, and death
02/20/2003CA2456236A1 Methods of screening based on the egf receptor crystal structure
02/20/2003CA2455951A1 Bi-directional synthesis of oligoguanidine transport agents
02/20/2003CA2455430A1 Sugar and lipid metabolism regulators in plants iii
02/20/2003CA2455200A1 Starch modification
02/20/2003CA2455027A1 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
02/20/2003CA2454768A1 Molecule
02/20/2003CA2454251A1 Isolation and mobilization of stem cells expressing vegfr-1
02/20/2003CA2454246A1 Cysteine mutants and methods for detecting ligand binding to biological molecules
02/20/2003CA2453995A1 Tacis and br3 polypeptides and uses thereof
02/20/2003CA2453327A1 Stress-associated genetic products from ashbya gossypii
02/20/2003CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer
02/20/2003CA2452842A1 13 human secreted proteins
02/20/2003CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
02/20/2003CA2430642A1 Plant seed specific promoters
02/20/2003CA2425040A1 Novel rice gene controlling tolerance to salt stress
02/19/2003WO2004015060A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
02/19/2003EP1284423A2 Adrenic acid (delta 7,10,13,16 docosatetraenoic acid ) receptor and uses thereof
02/19/2003EP1284298A2 Identification and use of molecules implicated in pain
02/19/2003EP1284297A2 Identification and use of molecules implicated in pain
02/19/2003EP1284292A2 Human B-cell Translocation Gene-3
02/19/2003EP1284291A1 Human pgc-1 promoter
02/19/2003EP1284290A1 Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
02/19/2003EP1284289A1 Method of examining allergic disease
02/19/2003EP1284288A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
02/19/2003EP1283905A2 Diagnosis of diseases associated with the cell cycle
02/19/2003EP1283897A2 Gene responsible for stargardt-like dominant macular dystrophy
02/19/2003EP1283887A1 Chimeric arterivirus-like particles
02/19/2003EP1283886A2 Intracellular signaling proteins
1 ... 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 ... 2916